Insights into ZIKV-Mediated Innate Immune Responses in Human Dermal Fibroblasts and Epidermal Keratinocytes
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Ji-Ae | - |
dc.contributor.author | Seong, Rak-Kyun | - |
dc.contributor.author | Son, Sang Wook | - |
dc.contributor.author | Shin, Ok Sarah | - |
dc.date.accessioned | 2021-09-01T20:19:12Z | - |
dc.date.available | 2021-09-01T20:19:12Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2019-02 | - |
dc.identifier.issn | 0022-202X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/67866 | - |
dc.description.abstract | Zika virus (ZIKV) has emerged as a global pathogen causing significant public health concern. ZIKV infections in humans principally occur via mosquito bites. Thus, host skin cells are permissive to ZIKV infection and are the first line of defense against the virus. Here, we examined the role and mechanisms of antiviral skin immunity against ZIKV infection. ZIKV infection (African lineage MR766) in human dermal fibroblasts, human epidermal keratinocytes, and HaCaT keratinocytes resulted in distinct expression changes in RIG-Ielike receptors, such as RIG-I and MDA5. Inhibition of RIG-I using small interfering RNA resulted in increased viral gene expression and reduced induction of IFNs and IFN-stimulated genes. Furthermore, ZIKV NS1 directly interacted with RIG-I or MDA5 and down-regulated RIG-Ielike receptoremediated antiviral signaling pathways. Asian lineage ZIKV (PRVABC59) infection also showed a distinct pattern of antiviral immunity in human skin cells, compared with other ZIKV strains. Additionally, ZIKV infections in human neural progenitor cells induced the robust activation of RIG-Ielike receptoremediated signaling, followed by highly enhanced IFN-stimulated gene expression. Our findings provide important insights into ZIKV tropism and subsequent antiviral signaling pathways that regulate ZIKV replication in human dermal fibroblasts and human epidermal keratinocytes. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCIENCE INC | - |
dc.subject | RIG-I | - |
dc.subject | MEMBRANE ASSOCIATION | - |
dc.subject | VIRUS | - |
dc.subject | RNA | - |
dc.subject | MDA5 | - |
dc.subject | RECOGNITION | - |
dc.subject | INFECTION | - |
dc.subject | HELICASES | - |
dc.subject | BIOLOGY | - |
dc.title | Insights into ZIKV-Mediated Innate Immune Responses in Human Dermal Fibroblasts and Epidermal Keratinocytes | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Son, Sang Wook | - |
dc.contributor.affiliatedAuthor | Shin, Ok Sarah | - |
dc.identifier.doi | 10.1016/j.jid.2018.07.038 | - |
dc.identifier.scopusid | 2-s2.0-85056809368 | - |
dc.identifier.wosid | 000456162000030 | - |
dc.identifier.bibliographicCitation | JOURNAL OF INVESTIGATIVE DERMATOLOGY, v.139, no.2, pp.391 - 399 | - |
dc.relation.isPartOf | JOURNAL OF INVESTIGATIVE DERMATOLOGY | - |
dc.citation.title | JOURNAL OF INVESTIGATIVE DERMATOLOGY | - |
dc.citation.volume | 139 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 391 | - |
dc.citation.endPage | 399 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Dermatology | - |
dc.relation.journalWebOfScienceCategory | Dermatology | - |
dc.subject.keywordPlus | RIG-I | - |
dc.subject.keywordPlus | MEMBRANE ASSOCIATION | - |
dc.subject.keywordPlus | VIRUS | - |
dc.subject.keywordPlus | RNA | - |
dc.subject.keywordPlus | MDA5 | - |
dc.subject.keywordPlus | RECOGNITION | - |
dc.subject.keywordPlus | INFECTION | - |
dc.subject.keywordPlus | HELICASES | - |
dc.subject.keywordPlus | BIOLOGY | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.